findmyKOL
Clinical trialNCT00867516CompletedPhase 2Interventional

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

SponsorCSL BehringEnrollment127Arthritis, Rheumatoid
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety and efficacy of ALD518 in three different doses in patients who have not had an adequate response to methotrexate.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • K-W Musculoskeletal Research, Inc.

    Kitchener, Ontario, Canada

  • Rheumatology Research Associates

    Ottawa, Ontario, Canada

Georgia
  • Medulla Chemotherapy and Immunotherapy Clinic

    Tbilisi, Georgia

  • V. Tsitlanadze Scientific Practical Centre of Rheumatology

    Tbilisi, Georgia

India
  • Chanre Rheumatology and Immunology Center and Research

    Malleshwaram, Bangalore, India

  • Kle Society Hospital and Medical Research Centre

    Nehru Nagar, Belgaum, India

  • Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopaedics

    Ramadaspeth, Nagpur, India

  • St. John'S Medical College Hospital

    Bangalore, India

  • Krishna Institute of Medical Sciences Ltd.

    Secunderabad, India

Poland
  • Miriada Center Private Clinic of Professor Sierakowski

    Bialystok, Poland

  • Nonpublic Centre of Medical Care Reumed

    Lublin, Poland

  • Novamed - Medical Center of Poznan

    Poznan, Poland

  • Provincional Rheumatological Complex Named After Dr Jadwiga Titz-Kosko

    Sopot, Poland

  • Szezecin Clinic of Rheumatology and Internal Diseases

    Szczecin, Poland

Russia
  • Regional Clinical Hospital of War Veterans

    Kemerovo, Russia

  • Institute of Clinical and Experimental Lymphology

    Novosibirsk, Russia

  • Ryazan Regional Clinical Cardiologic Dispensary

    Ryazan, Russia

  • City Hospital #26

    Saint Petersburg, Russia

  • Saint Petersburg Medical Academy of Postgraduate Study

    Saint Petersburg, Russia

  • Saint-Petersburg State Medical Academy Named After I. I. Mechnikov

    Saint Petersburg, Russia

  • Regional War Veterans' Hospital

    Saratov, Russia

  • Tomsk Regional Clinical Hospital

    Tomsk, Russia

  • Tula Regional Clinical Hospital

    Tula, Russia

  • Clinical Hospital of Emergency Care Named After N.V. Solovyev

    Yaroslavl, Russia

Serbia
  • Institute of Rheumatology

    Belgrade, Serbia

  • Institute for Rehabilitation and Treatment Niska Banja

    Niška Banja, Serbia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ALD518Infusion without ALD518'
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2008
Primary completion
30 Jun 2009
Completion
31 Dec 2009
Last update posted
9 Jul 2020
Registered enrollment
127
Registry id
NCT00867516
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.